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The effect of recombinant human granulocyte colony-stimulating factor (G-CSF) on induction of differen- 
tiation of mouse myeloid leukemic M 1 cells was examined. Purified G-CSF caused dose-dependent i duc- 
tion of phagocytic activity and lysozyme activity in M 1 cells. Its half-maximally effective concentration was 
10 ng/ml. On trcatmcnt of MI cells with G-CSF (100 ng/ml) for 4 days, 30-507; of the cells differentiated 
morphologically into macrophage c lls: 30-40% of the cells were blast cells and 20-30% of the cells were 
forms intermcdiate b tween blastic cells and mature macrophages. 
Recombinant granuloo,te colony-stimulating Jactor ( Myeloid leukemic ell) 
Differentiation-inducing factor 
Differentiation Macrophage 
1. INTRODUCTION 
Mouse myeloid leukemic M I cells can be in- 
duced to differentiate into macrophages by protein 
inducers (D-factors) and various chemicals [1,2]. 
On differentiation, M1 cells express morphologi- 
cal, biochemical and functional characteristics of 
normal macrophages, such as phagocytic and loco- 
motive activities, lysosomal enzyme activities, Fc 
and C3 receptors and prostaglandin production 
[1,2]. On differentiation, M1 cells lose their 
leukemogenicity in syngeneic mice [1], and injec- 
tion of D-factor preparations into mice inoculated 
with M1 cells prolongs the survival of the mice [3]. 
Therefore, inducers of differentiation of myeloid 
leukemic cells might be effective in the therapy of 
myeloid leukemia [2,3]. 
Abbreviations: G-CSF, granulocyte colony-stimulating 
factor; D-factor, differentiation-inducing factor; 
cDNA, complementary DNA 
We purified the D-factor from conditioned 
medium of mouse fibroblast L929 cells [4] and 
mouse Ehrlich ascites tumor cells [5]. Even at 
higher concentrations, the D-factor did not induce 
colony formation of macrophages or granulocytes 
from normal bone marrow cells. Recently, we 
determined the sequence of the NHz-terminal 
amino acids of the factor (unpublished), finding 
that they differed from those of the CSFs (growth 
factors for normal precursors of macrophages 
and/or granulocytes) o far reported. 
On the other hand, Nicola et al. [6] reported that 
the differentiation factor for mouse 
myelomonocytic leukemic WEHI-3B cells is G- 
CSF, and Souza et al. [7] showed that recombinant 
human G-CSF derived from bladder carcinoma 
5637 cells induced differentiation of WEHI-3B 
cells and human leukemic cells. We also cloned a 
cDNA copy of the gene encoding human G-CSF 
from a cDNA library constructed from mRNA in 
macrophages [8]. In the present work, we exam- 
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ined the effect of recombinant human G-CSF on 
induction of the differentiation of M I cells. 
2. MATERIALS AND METHODS 
dividual cells were traced. Each cell image was 
digitalized with a data tablet digitizer and pro- 
cessed on an on-line minicomputer YhlP-2108A. 
The cell area S(C), nuclear area S(N), and nucleus- 
cell ratio NCR = 100 x S(N)/S(C) were calculated. 
2.1. Cells and cell culture 
Myeloid leukemic MI cells originated from a 
spontaneous myeloid leukemia in an SL mouse [I]. 
Subclones of M I cells, clone T22 and newly 
isolated T22-3 cells were used in the present study. 
The cells were cultured in Eagle's minimal essential 
medium (Nissui Seiyaku Co., Tokyo, Japan), sup- 
plemented with double the usual concentrations of
amino acids and vitamins and 10% (v/v) heat- 
inactivated (56°C for 30 min) call" serum at 37°C 
under 507o CO2 in air. 
2.5., Phugocytosis 
Suspensions of cells (1-2 x 1(/') in 1 ml of 
serum-free Eagle's medium containing 0.2% of a 
suspension of polystyrene latex particles (average 
diameter, 1.099/~m; Dow Chemical Co., In- 
dianapolis, IN) were incubated for 4 h at 37°C. 
Then the cells were thoroughly washed 3 times with 
phosphate-buffered saline, and the percentage of 
phagocytic ells in more than 200 cells was deter- 
mined. Cells containing more than 10 latex par- 
ticles were scored as phagocytic ells. 
2.2. G-CSF 
A cDNA clone of the gene encoding human G- 
CSF was isolated from a eDNA library constructed 
from mRNA in human macrophages a described 
[8]. The amino acid sequence deduced from the 
cloned G-CSF eDNA was identical with that 
reported by Souza et al. [7]. The G-CSF eDNA was 
expressed in E. coli. K12 MM294 by construction 
of an expression plasmid for G-CSF using pGEL-1 
containing the trp promoter, and the mature G- 
CSF was purified to homogeneity by the method of 
Marston et al. [9]. The purified G-CSF (1 mg pro- 
tein) induced 10 a granulocyte colonies from human 
bone marrow cells in agar culture. 
2.3. D-factor 
D-factor was purified to homogeneity from con- 
ditioned medium of Ehrlich ascites tumor cells as 
described [5]. Its specific activity was 6.4 × 
10 v U/mg protein. 50 U of D-factor were defined 
as the activity inducing 50% phagocytic ells in 
1 ml of M1 cell culture. 
2.4. Cell motphology 
Morphological analysis of MI cells was per- 
formed by the method of Hayashi et al. [10,11]. 
Cell preparations were made using a cytocentrifuge 
and the cells were stained with May-Gr~inwald- 
Giemsa solution. Microscopic fields were pro- 
jected onto paper screens at 2000-fold magnifica- 
tion with a Nikon Micropan microprojector, and 
the perimeters of the cytoplasm and nucleus of in- 
2.6. kysozyme 
Lysozyme activity in the cells was determined by 
the lysoplate method of Osserman and Lawtor [12] 
as modified by Kasukabe et al. [13]. The activity, 
in microgram equivalents of hen egg white 
lysozyme, was calculated from a standard curve 
prepared using purified hen egg white lysozyme. 
The results are expressed as amounts of lysozyme 
in microgram equivalents per mg of cell protein. 
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Fig. 1. Induction of phagocytic activity in M 1 cells by G- 
CSF. MI cells were incubated for 2 days with various 
concentrations of G-CSF and then their phagocytic 
activity for polystyrene latex particles was assayed. 
Points and bars are means + SE for duplicate 
determinations. 
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3. RESULTS 
3.1. Induction of the differentiation of M1 cells by 
G-CSF 
Rccoinbinant human G-CSF induced phagocytic 
activity, a typical marker of  cell differentiation in 
M1 cells. G-CSF caused dose-dependent induction 
and its half-maximal concentration was 10 ng/ml 
(fig. l). The proportion of phagocytic cells in- 
creased with increase in the incubation time for 4 
days (fig.2). G-CSF also induced lysozyme activity 
in M1 cells; lysozyme activity in the cells treated 
with 100 ng G-CSF per ml for 4 days was 
4.1 U/mg protein, whereas that in untreated M1 
cells was 0.4 U/rag protein. 
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Fig.2. Induction of  phagocytic activity in M 1 cells after 
different times of incubation with G-CSF (60 ng/ml). 
Points and bars are means _+ SE for duplicate 
determinations. 
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Fig.3. Growth o f  M l  (T22-3 clone) cells. Cells were 
cultured in the presence of 60 ng/ml of G-CSF (o) or 
500 U/ml of D-factor (zx) per ml or in the absence of 
factors (o). On day 3, cultures were diluted with fresh 
medium to avoid nutrient depletion. Cell numbers were 
counted with a Coulter counter. Values indicate 
cumulative cell numbers. 
Culture of M I cells in the presence of G-CSF 
resulted in slight reduction in proliferation of  the 
cells (fig.3), but increase in the cell number did not 
stop even after their treatment with G-CSF for 7 
days. Cell morphology was examined by staining 
the cells with May-Gr/inwald-Giemsa solution. As 
shown in fig.4a, untreated MI cells had a large 
round or slightly indented nucleus and little 
a 
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Fig.4. Morphology of M1 cells stained with May- 
Griinwald-Giemsa stain. The bar represents 10,am. (a) 
Untreated clone T22-3 cells; (b) ceils treated with G-CSF 
(100 ng/ml) for 4 days; (c) cells treated with D-factor 
(500 U/ml) for 4 days. 
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cytoplasm. After treatment with G-CSF for 4 days, 
60-7007o of the cells changed morphologically; 
30-50% of the cells were similar to macrophages, 
as shown in fig.4b, while 20-30% were forms in- 
termediate between blastic cells and mature macro- 
phages. The nucleus-cell ratio of individual cells 
was determined and the frequency distributions of 
the cells are shown in fig.5. On differentiation, M1 
cells showed decrease in the nucleus-cell ratio. 
However, even a higher concentration of G-CSF 
(200 ng/ml) did not induce phagocytic activity in 
clone R1 cells [14], a subclone of M1 cells that was 
resistant to induction of differentiation by D- 
factor (10000 U/ml). 
3.2. Comparison of G-CSF and D-factor 
Under the same conditions we examined the ef- 
fects of D-factor and G-CSF on the induction of 
differentiation and growth of M I cells. The max- 
imum percentage of phagocytic cells induced by G- 
CSF was 60-70% (figs 1 and 2). On the other 
hand, D-factor purified from conditioned medium 
of L929 cells or Ehrlich ascites tumor cells induced 
phagocytic activity in more than 90% of the M1 
cells [4,5]. On treatment of M1 cells with D-factor 
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Fig.5. Morphological analysis of M 1 cells. (a) Untreated 
clone T22-3 cells; (b) cells treated with G-CSF 
(100 ng/ml) for 4 days; (c) cells treated with D-factor 
(500 U/ml) for 4 days. The nucleus-cell ratio of cells was 
determined as described in section 2 on 50 randomly 
selected cells. 
purified to homogeneity from conditioned medium 
of Ehrlich ascites tumor cells, more than 99% of 
the M1 cells differentiated into macrophages (figs 
4c and 5) and growth of the cells ceased after 2 
days (fig.3). The nucleus-cell ratios of the cells 
treated with D-factor for 4 days were less than 
40%, while those of cells treated with G-CSF were 
widely distributed between 20 and 70% (fig.5). 
4. DISCUSSION 
In this work, we showed that recombinant 
human G-CSF induced differentiation of mouse 
myeloid leukemic M1 cells into cells that were 
functionally, biochemically and morphologically 
similar to macrophages. The half-maximal concen- 
tration of G-CSF for inducing differentiation of 
M1 cells was 10 ng/ml, or5.3 x 10 -u) M, since the 
molecular mass of G-CSF deduced from the amino 
acid sequence is 18700 Da. On the other hand, the 
half-maximally effective concentration of D-factor 
on M1 cells was 2 x 10 -1~ M [4,5]. Souza et al. [7] 
reported that recombinant human G-CSF showed 
activity on both human bone marrow cells and a 
mouse myelomonocytic leukemia cell line 
WEHI-3B with a half-maximally effective concen- 
tration of 2.7 x 10 -1[ M. Therefore, the action of 
G-CSF is not species pecific. Although G-CSF can 
support growth of mixed colony progenitors 
(colony-forming unit-granulocyte, erythroid, 
macrophage and megakaryocyte), it mainly 
stimulates growth and function of granulocytes in
normal hematopoietic cells [7]. Therefore, the low 
sensitivity of M 1 cells to G-CSF may be associated 
with the inherent character of M1 cells to differen- 
tiate predominantly into macrophages. 
Even under the optimum conditions of differen- 
tiation of M1 cells induced by G-CSF, 30-40% 
blastic cells remained. The nucleus-cell ratios of 
these cells were more than 50%. Hayashi et al. 
[10,11 ] examined the relation between the nucleus- 
cell ratio of M1 cells and the ability of the cells to 
proliferate. They showed that differentiated M1 
cells in which the nucleus-cell ratio decreased to 
below 40% lost the ability to enter the S phase of 
the cell cycle. The nucleus-cell ratios of more than 
99% of the cells treated with D-factor were less 
than 40%, whereas those of cells treated with G- 
CSF were widely distributed between 20 and 70% 
(fig.5). These results are consistent with results on 
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the effects of G-CSF and D-factor on growth of 
MI cells (fig.3). Growth of MI ceils was sup- 
pressed completely by D-factor and partially by 
G-CSF. 
We previously showed that there are two types 
of D-factor for M1 cells, which differ from each 
other in antigenicity and molecular size [5,13]. The 
D-factor with a molecular mass of 
40000-70000 Da is produced by mouse L929 cells, 
Ehrlich ascites tumor cells and activated lym- 
phocytes [15,16], and a purified preparation of this 
D-factor did not show CSF activity [5,16]. The 
other D-factor with a molecular mass of 
20000-25 000 Da is produced by macrophages and 
has not yet been purified. G-CSF is also produced 
by macrophages [17] and the molecular mass of its 
glycosylated form is 25 000 Da [6]. Therefore, the 
D-factor for M I cells produced by macrophages 
might be identical to G-CSF. Elucidation of this 
problem should be facilitated by the availability of 
antibody to G-CSF. 
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